Silicosis is the most common pneumoconiosis globally, with higher prevalence and incidence in developing countries. To date, there is no effective treatment to halt or reverse the disease progression caused by silica-induced lung injury. Significant advances have to be made in order to reduce morbidity and mortality related to silicosis. In this review, we have highlighted the main mechanisms of action that cause lung damage by silica particles and summarized the data concerning the therapeutic promise of cell-based therapy for silicosis.
Cell-Based Therapy for Silicosis
M. Lopes-Pacheco,E. Bandeira,M. Morales
Published 2016 in Stem Cells International
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
Stem Cells International
- Publication date
2016-03-15
- Fields of study
Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-95 of 95 citing papers · Page 1 of 1